Pricing Log in Create free account

Edgewise Therapeutics, Inc. (EWTX) vs Legend Biotech Corporation Sponsored ADR (LEGN)

Edgewise Therapeutics, Inc. and Legend Biotech Corporation Sponsored ADR are both Biotechnology companies. Edgewise Therapeutics, Inc. and Legend Biotech Corporation Sponsored ADR are of similar size ($4.2B and $3.8B). Edgewise Therapeutics, Inc. has the higher net margin (0.00% vs −7.20%) and the higher return on invested capital (0.00% vs −9.54%). Across the 14 metrics below, Edgewise Therapeutics, Inc. leads on 7 and Legend Biotech Corporation Sponsored ADR on 7.

Valuation

Metric EWTX LEGN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2.72 9.71
P/B 8.94 2.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.22 9.21
Earnings yield (4.97%) (2.68%) (33.15%)
Free cash flow yield (3.97%) (3.54%) (25.50%)

Profitability

Metric EWTX LEGN Biotechnology median
Gross margin 0.00% 56.58% 65.16%
Operating margin 0.00% (5.06%) 0.00%
Net margin 0.00% (7.20%) 0.00%
Free cash flow margin 0.00% (9.58%) 0.00%
Return on equity (38.03%) (8.08%) (56.36%)
Return on assets (36.09%) (5.32%) (48.04%)
Return on invested capital 0.00% (9.54%) 0.00%

Growth

Metric EWTX LEGN Biotechnology median
Revenue growth (TTM) — 59.55% 6.02%
EPS growth (last fiscal year) (12.41%) (66.34%) 30.26%
Revenue growth, 5-year CAGR — 65.93% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EWTX LEGN Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 16.24 3.04 4.72
Net debt to EBITDA 2.69 2.31 0.96

Dividend

Metric EWTX LEGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EWTX LEGN Biotechnology median
Market cap 4.15b 3.84b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack